世界のヒトパピローマウイルス治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Human Papillomaviru Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2957
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、ヒトパピローマウイルス治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫調節剤、角質溶解剤、抗腫瘍剤、シネカテキン）、用途別市場規模（生殖器疣贅、生殖器癌、疣冗長表皮異形成症、口腔乳頭腫、中咽頭癌、喉頭乳頭腫症、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・ヒトパピローマウイルス治療の市場動向
・企業の競争状況、市場シェア
・ヒトパピローマウイルス治療の種類別市場規模（免疫調節剤、角質溶解剤、抗腫瘍剤、シネカテキン）
・ヒトパピローマウイルス治療の用途別市場規模（生殖器疣贅、生殖器癌、疣冗長表皮異形成症、口腔乳頭腫、中咽頭癌、喉頭乳頭腫症、その他）
・ヒトパピローマウイルス治療の北米市場規模2016-2027（アメリカ、カナダ）
・ヒトパピローマウイルス治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・ヒトパピローマウイルス治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ヒトパピローマウイルス治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・ヒトパピローマウイルス治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AbbVie、Teva Pharmaceutical、Clinigen Group、Merck、Perrigo Company、Roche、Bausch Health）
・結論

Market Analysis and Insights: Global Human Papillomaviru Therapeutics Market
The global Human Papillomaviru Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Human Papillomaviru Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Human Papillomaviru Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Human Papillomaviru Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Human Papillomaviru Therapeutics market.

Global Human Papillomaviru Therapeutics Scope and Market Size
Human Papillomaviru Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Papillomaviru Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immunomodulators
Keratolytic Agents
Anti-neoplastic Agents
Sinecatechins

Segment by Application
Genital Warts
Genital Cancer
Epidermodysplasia Verruciformis
Oral Papillomas
Oropharyngeal Cancer
Laryngeal Papillomatosis
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Teva Pharmaceutical
Clinigen Group
Merck
Perrigo Company
Roche
Bausch Health

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Papillomaviru Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunomodulators
1.2.3 Keratolytic Agents
1.2.4 Anti-neoplastic Agents
1.2.5 Sinecatechins
1.3 Market by Application
1.3.1 Global Human Papillomaviru Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Genital Warts
1.3.3 Genital Cancer
1.3.4 Epidermodysplasia Verruciformis
1.3.5 Oral Papillomas
1.3.6 Oropharyngeal Cancer
1.3.7 Laryngeal Papillomatosis
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Human Papillomaviru Therapeutics Market Perspective (2016-2027)
2.2 Human Papillomaviru Therapeutics Growth Trends by Regions
2.2.1 Human Papillomaviru Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Human Papillomaviru Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Human Papillomaviru Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Human Papillomaviru Therapeutics Industry Dynamic
2.3.1 Human Papillomaviru Therapeutics Market Trends
2.3.2 Human Papillomaviru Therapeutics Market Drivers
2.3.3 Human Papillomaviru Therapeutics Market Challenges
2.3.4 Human Papillomaviru Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Human Papillomaviru Therapeutics Players by Revenue
3.1.1 Global Top Human Papillomaviru Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Human Papillomaviru Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Human Papillomaviru Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Human Papillomaviru Therapeutics Revenue
3.4 Global Human Papillomaviru Therapeutics Market Concentration Ratio
3.4.1 Global Human Papillomaviru Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Papillomaviru Therapeutics Revenue in 2020
3.5 Human Papillomaviru Therapeutics Key Players Head office and Area Served
3.6 Key Players Human Papillomaviru Therapeutics Product Solution and Service
3.7 Date of Enter into Human Papillomaviru Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Human Papillomaviru Therapeutics Breakdown Data by Type
4.1 Global Human Papillomaviru Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Human Papillomaviru Therapeutics Forecasted Market Size by Type (2022-2027)

5 Human Papillomaviru Therapeutics Breakdown Data by Application
5.1 Global Human Papillomaviru Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Human Papillomaviru Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Human Papillomaviru Therapeutics Market Size (2016-2027)
6.2 North America Human Papillomaviru Therapeutics Market Size by Type
6.2.1 North America Human Papillomaviru Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Human Papillomaviru Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Human Papillomaviru Therapeutics Market Size by Type (2016-2027)
6.3 North America Human Papillomaviru Therapeutics Market Size by Application
6.3.1 North America Human Papillomaviru Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Human Papillomaviru Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Human Papillomaviru Therapeutics Market Size by Application (2016-2027)
6.4 North America Human Papillomaviru Therapeutics Market Size by Country
6.4.1 North America Human Papillomaviru Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Human Papillomaviru Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Human Papillomaviru Therapeutics Market Size (2016-2027)
7.2 Europe Human Papillomaviru Therapeutics Market Size by Type
7.2.1 Europe Human Papillomaviru Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Human Papillomaviru Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Human Papillomaviru Therapeutics Market Size by Type (2016-2027)
7.3 Europe Human Papillomaviru Therapeutics Market Size by Application
7.3.1 Europe Human Papillomaviru Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Human Papillomaviru Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Human Papillomaviru Therapeutics Market Size by Application (2016-2027)
7.4 Europe Human Papillomaviru Therapeutics Market Size by Country
7.4.1 Europe Human Papillomaviru Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Human Papillomaviru Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Human Papillomaviru Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Human Papillomaviru Therapeutics Market Size by Type
8.2.1 Asia-Pacific Human Papillomaviru Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Human Papillomaviru Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Human Papillomaviru Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Human Papillomaviru Therapeutics Market Size by Application
8.3.1 Asia-Pacific Human Papillomaviru Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Human Papillomaviru Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Human Papillomaviru Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Human Papillomaviru Therapeutics Market Size by Region
8.4.1 Asia-Pacific Human Papillomaviru Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Human Papillomaviru Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Human Papillomaviru Therapeutics Market Size (2016-2027)
9.2 Latin America Human Papillomaviru Therapeutics Market Size by Type
9.2.1 Latin America Human Papillomaviru Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Human Papillomaviru Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Human Papillomaviru Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Human Papillomaviru Therapeutics Market Size by Application
9.3.1 Latin America Human Papillomaviru Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Human Papillomaviru Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Human Papillomaviru Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Human Papillomaviru Therapeutics Market Size by Country
9.4.1 Latin America Human Papillomaviru Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Human Papillomaviru Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Human Papillomaviru Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Human Papillomaviru Therapeutics Market Size by Type
10.2.1 Middle East & Africa Human Papillomaviru Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Human Papillomaviru Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Human Papillomaviru Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Human Papillomaviru Therapeutics Market Size by Application
10.3.1 Middle East & Africa Human Papillomaviru Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Human Papillomaviru Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Human Papillomaviru Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Human Papillomaviru Therapeutics Market Size by Country
10.4.1 Middle East & Africa Human Papillomaviru Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Human Papillomaviru Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Human Papillomaviru Therapeutics Introduction
11.1.4 AbbVie Revenue in Human Papillomaviru Therapeutics Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Teva Pharmaceutical
11.2.1 Teva Pharmaceutical Company Details
11.2.2 Teva Pharmaceutical Business Overview
11.2.3 Teva Pharmaceutical Human Papillomaviru Therapeutics Introduction
11.2.4 Teva Pharmaceutical Revenue in Human Papillomaviru Therapeutics Business (2016-2021)
11.2.5 Teva Pharmaceutical Recent Development
11.3 Clinigen Group
11.3.1 Clinigen Group Company Details
11.3.2 Clinigen Group Business Overview
11.3.3 Clinigen Group Human Papillomaviru Therapeutics Introduction
11.3.4 Clinigen Group Revenue in Human Papillomaviru Therapeutics Business (2016-2021)
11.3.5 Clinigen Group Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Human Papillomaviru Therapeutics Introduction
11.4.4 Merck Revenue in Human Papillomaviru Therapeutics Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Perrigo Company
11.5.1 Perrigo Company Company Details
11.5.2 Perrigo Company Business Overview
11.5.3 Perrigo Company Human Papillomaviru Therapeutics Introduction
11.5.4 Perrigo Company Revenue in Human Papillomaviru Therapeutics Business (2016-2021)
11.5.5 Perrigo Company Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Human Papillomaviru Therapeutics Introduction
11.6.4 Roche Revenue in Human Papillomaviru Therapeutics Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Bausch Health
11.7.1 Bausch Health Company Details
11.7.2 Bausch Health Business Overview
11.7.3 Bausch Health Human Papillomaviru Therapeutics Introduction
11.7.4 Bausch Health Revenue in Human Papillomaviru Therapeutics Business (2016-2021)
11.7.5 Bausch Health Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Human Papillomaviru Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunomodulators
Table 3. Key Players of Keratolytic Agents
Table 4. Key Players of Anti-neoplastic Agents
Table 5. Key Players of Sinecatechins
Table 6. Global Human Papillomaviru Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Human Papillomaviru Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Human Papillomaviru Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Human Papillomaviru Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Human Papillomaviru Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Human Papillomaviru Therapeutics Market Share by Regions (2022-2027)
Table 12. Human Papillomaviru Therapeutics Market Trends
Table 13. Human Papillomaviru Therapeutics Market Drivers
Table 14. Human Papillomaviru Therapeutics Market Challenges
Table 15. Human Papillomaviru Therapeutics Market Restraints
Table 16. Global Human Papillomaviru Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Human Papillomaviru Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Human Papillomaviru Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Papillomaviru Therapeutics as of 2020)
Table 19. Ranking of Global Top Human Papillomaviru Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Human Papillomaviru Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Human Papillomaviru Therapeutics Product Solution and Service
Table 23. Date of Enter into Human Papillomaviru Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Human Papillomaviru Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Human Papillomaviru Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Human Papillomaviru Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Human Papillomaviru Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Human Papillomaviru Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Human Papillomaviru Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Human Papillomaviru Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Human Papillomaviru Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Human Papillomaviru Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Human Papillomaviru Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Human Papillomaviru Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Human Papillomaviru Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Human Papillomaviru Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Human Papillomaviru Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Human Papillomaviru Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Human Papillomaviru Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Human Papillomaviru Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Human Papillomaviru Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Human Papillomaviru Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Human Papillomaviru Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Human Papillomaviru Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Human Papillomaviru Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Human Papillomaviru Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Human Papillomaviru Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Human Papillomaviru Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Human Papillomaviru Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Human Papillomaviru Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Human Papillomaviru Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Human Papillomaviru Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Human Papillomaviru Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Human Papillomaviru Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Human Papillomaviru Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Human Papillomaviru Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Human Papillomaviru Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Human Papillomaviru Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Human Papillomaviru Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Human Papillomaviru Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Human Papillomaviru Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. AbbVie Company Details
Table 64. AbbVie Business Overview
Table 65. AbbVie Human Papillomaviru Therapeutics Product
Table 66. AbbVie Revenue in Human Papillomaviru Therapeutics Business (2016-2021) & (US$ Million)
Table 67. AbbVie Recent Development
Table 68. Teva Pharmaceutical Company Details
Table 69. Teva Pharmaceutical Business Overview
Table 70. Teva Pharmaceutical Human Papillomaviru Therapeutics Product
Table 71. Teva Pharmaceutical Revenue in Human Papillomaviru Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Teva Pharmaceutical Recent Development
Table 73. Clinigen Group Company Details
Table 74. Clinigen Group Business Overview
Table 75. Clinigen Group Human Papillomaviru Therapeutics Product
Table 76. Clinigen Group Revenue in Human Papillomaviru Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Clinigen Group Recent Development
Table 78. Merck Company Details
Table 79. Merck Business Overview
Table 80. Merck Human Papillomaviru Therapeutics Product
Table 81. Merck Revenue in Human Papillomaviru Therapeutics Business (2016-2021) & (US$ Million)
Table 82. Merck Recent Development
Table 83. Perrigo Company Company Details
Table 84. Perrigo Company Business Overview
Table 85. Perrigo Company Human Papillomaviru Therapeutics Product
Table 86. Perrigo Company Revenue in Human Papillomaviru Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Perrigo Company Recent Development
Table 88. Roche Company Details
Table 89. Roche Business Overview
Table 90. Roche Human Papillomaviru Therapeutics Product
Table 91. Roche Revenue in Human Papillomaviru Therapeutics Business (2016-2021) & (US$ Million)
Table 92. Roche Recent Development
Table 93. Bausch Health Company Details
Table 94. Bausch Health Business Overview
Table 95. Bausch Health Human Papillomaviru Therapeutics Product
Table 96. Bausch Health Revenue in Human Papillomaviru Therapeutics Business (2016-2021) & (US$ Million)
Table 97. Bausch Health Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Papillomaviru Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Immunomodulators Features
Figure 3. Keratolytic Agents Features
Figure 4. Anti-neoplastic Agents Features
Figure 5. Sinecatechins Features
Figure 6. Global Human Papillomaviru Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Genital Warts Case Studies
Figure 8. Genital Cancer Case Studies
Figure 9. Epidermodysplasia Verruciformis Case Studies
Figure 10. Oral Papillomas Case Studies
Figure 11. Oropharyngeal Cancer Case Studies
Figure 12. Laryngeal Papillomatosis Case Studies
Figure 13. Others Case Studies
Figure 14. Human Papillomaviru Therapeutics Report Years Considered
Figure 15. Global Human Papillomaviru Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Human Papillomaviru Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Human Papillomaviru Therapeutics Market Share by Regions: 2020 VS 2027
Figure 18. Global Human Papillomaviru Therapeutics Market Share by Regions (2022-2027)
Figure 19. Global Human Papillomaviru Therapeutics Market Share by Players in 2020
Figure 20. Global Top Human Papillomaviru Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Papillomaviru Therapeutics as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Human Papillomaviru Therapeutics Revenue in 2020
Figure 22. Global Human Papillomaviru Therapeutics Revenue Market Share by Type (2016-2021)
Figure 23. Global Human Papillomaviru Therapeutics Revenue Market Share by Type (2022-2027)
Figure 24. North America Human Papillomaviru Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Human Papillomaviru Therapeutics Market Share by Type (2016-2027)
Figure 26. North America Human Papillomaviru Therapeutics Market Share by Application (2016-2027)
Figure 27. North America Human Papillomaviru Therapeutics Market Share by Country (2016-2027)
Figure 28. United States Human Papillomaviru Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Human Papillomaviru Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Human Papillomaviru Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Human Papillomaviru Therapeutics Market Share by Type (2016-2027)
Figure 32. Europe Human Papillomaviru Therapeutics Market Share by Application (2016-2027)
Figure 33. Europe Human Papillomaviru Therapeutics Market Share by Country (2016-2027)
Figure 34. Germany Human Papillomaviru Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Human Papillomaviru Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Human Papillomaviru Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Human Papillomaviru Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Human Papillomaviru Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Human Papillomaviru Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Human Papillomaviru Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Human Papillomaviru Therapeutics Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Human Papillomaviru Therapeutics Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Human Papillomaviru Therapeutics Market Share by Region (2016-2027)
Figure 44. China Human Papillomaviru Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Human Papillomaviru Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Human Papillomaviru Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Human Papillomaviru Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Human Papillomaviru Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Human Papillomaviru Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Human Papillomaviru Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Human Papillomaviru Therapeutics Market Share by Type (2016-2027)
Figure 52. Latin America Human Papillomaviru Therapeutics Market Share by Application (2016-2027)
Figure 53. Latin America Human Papillomaviru Therapeutics Market Share by Country (2016-2027)
Figure 54. Mexico Human Papillomaviru Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Human Papillomaviru Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Human Papillomaviru Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Human Papillomaviru Therapeutics Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Human Papillomaviru Therapeutics Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Human Papillomaviru Therapeutics Market Share by Country (2016-2027)
Figure 60. Turkey Human Papillomaviru Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Human Papillomaviru Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Human Papillomaviru Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. AbbVie Revenue Growth Rate in Human Papillomaviru Therapeutics Business (2016-2021)
Figure 64. Teva Pharmaceutical Revenue Growth Rate in Human Papillomaviru Therapeutics Business (2016-2021)
Figure 65. Clinigen Group Revenue Growth Rate in Human Papillomaviru Therapeutics Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in Human Papillomaviru Therapeutics Business (2016-2021)
Figure 67. Perrigo Company Revenue Growth Rate in Human Papillomaviru Therapeutics Business (2016-2021)
Figure 68. Roche Revenue Growth Rate in Human Papillomaviru Therapeutics Business (2016-2021)
Figure 69. Bausch Health Revenue Growth Rate in Human Papillomaviru Therapeutics Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界のヒトマイクロバイオーム治療市場規模・現状・予測（2021年-2027年）

Global Human Microbiome Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z2955 2021年4月 99Pages
QYResearch社発行の本調査資料では、ヒトマイクロバイオーム治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（FMT、マイクロバイオーム治療薬）、用途別市場規模（クロストリジウム・ディフィシル、クローン病、炎症性腸疾患、糖尿病、その他）...

世界のヒト血漿由来治療市場規模・現状・予測（2021年-2027年）

Global Human Plasma-Derived Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z2961 2021年4月 97Pages
QYResearch社発行の本調査資料では、ヒト血漿由来治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アルブミン、免疫グロブリン、凝固因子、プロトロンビン複合体濃縮物、その他）、用途別市場規模（病院、クリニック、研究センター）、主要地域別...

世界のヒト免疫不全ウイルス（HIV）-1治療市場規模・現状・予測（2021年-2027年）

Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z2949 2021年4月 94Pages
QYResearch社発行の本調査資料では、ヒト免疫不全ウイルス（HIV）-1治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ヌクレオシドアナログ逆転写酵素阻害剤（NRTI）、非ヌクレオシド逆転写酵素阻害剤（NNRTI）、侵入・融合阻害剤、...

世界のヒトパピローマウイルス・サイトメガロウイルス治療市場規模・現状・予測（2021年-2027年）

Global Human Papillomavirus and Cytomegalovirus Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z2959 2021年4月 99Pages
QYResearch社発行の本調査資料では、ヒトパピローマウイルス・サイトメガロウイルス治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（医療、手術療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界のヒトマイクロバイオーム市場規模・現状・予測（2021年-2027年）

Global Human Microbiome Market Size, Status and Forecast 2021-2027
QYR2104Z2952 2021年4月 133Pages
QYResearch社発行の本調査資料では、ヒトマイクロバイオームのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（消化管ヒトマイクロバイオーム、泌尿生殖器ヒトマイクロバイオーム、その他）、用途別市場規模（治療、診断）、主要地域別市場規模（北米、...

世界のヒトマイクロバイオーム治療薬・診断市場規模・現状・予測（2021年-2027年）

Global Human Microbiome Based Drugs and Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z2951 2021年4月 95Pages
QYResearch社発行の本調査資料では、ヒトマイクロバイオーム治療薬・診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（治療、診断）、用途別市場規模（臨床研究所、病院、手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界のヒト絨毛性ゴナドトロピン市場規模・現状・予測（2021年-2027年）

Global Human Chorionic Gonadotropin Market Size, Status and Forecast 2021-2027
QYR2104Z2941 2021年4月 95Pages
QYResearch社発行の本調査資料では、ヒト絨毛性ゴナドトロピンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（天然資源抽出、組換え技術）、用途別市場規模（不妊治療クリニック、研究機関、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界のヒト絨毛性ゴナドトロピン市場規模・現状・予測（2021年-2027年）

世界のヒトパラインフルエンザウイルス診断市場規模・現状・予測（2021年-2027年）

Global Human Parainfluenza Viruses Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z2960 2021年4月 92Pages
QYResearch社発行の本調査資料では、ヒトパラインフルエンザウイルス診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（HPV検査、フォローアップHPV検査、共同検査）、用途別市場規模（子宮頸がん検診、膣がん検診、その他）、主要地域別市場...

世界のヒトパラインフルエンザウイルス診断市場規模・現状・予測（2021年-2027年）

世界の抗腫瘍剤市場 2021：企業別、地域別、種類・用途別 The Anti - Neoplastic Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
世界のヒトマイクロバイオーム治療市場規模・現状・予測（2021年-2027年） Human microbiome has co-evolved with humans for centuries, which includes bacteria, viruses, fungi, Achaeans etc. The human microbiome is now one of the fastest growing areas of biology, and is considered as a newly discovered organ with the potential to have a tremendous impact on human health. Mic…
世界のヒト血漿由来治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Human Plasma-Derived Therapeutics Market The global Human Plasma-Derived Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…
世界のヒト免疫不全ウイルス（HIV）-1治療市場規模・現状・予測（2021年-2027年） The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS).AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and can…
世界のヒトパピローマウイルス・サイトメガロウイルス治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Human Papillomavirus and Cytomegalovirus Therapeutics Market The global Human Papillomavirus and Cytomegalovirus Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-s…